OrthoPediatrics Raises FY2026 Sales Guidance from $262.000M-$266.000M to $263.000M-$267.000M vs $264.310M Est

Benzinga Newsdesk www.benzinga.com Positive 93.9%

Neg 0% Neu 0% Pos 93.9%

OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $262.000 million-$266.000 million to $263.000 million-$267.000 million vs $264.310 million estimate.